260 related articles for article (PubMed ID: 27825154)
1. Growth Factors for Skeletal Muscle Tissue Engineering.
Syverud BC; VanDusen KW; Larkin LM
Cells Tissues Organs; 2016; 202(3-4):169-179. PubMed ID: 27825154
[TBL] [Abstract][Full Text] [Related]
2. Effects of Dexamethasone on Satellite Cells and Tissue Engineered Skeletal Muscle Units.
Syverud BC; VanDusen KW; Larkin LM
Tissue Eng Part A; 2016 Mar; 22(5-6):480-9. PubMed ID: 26790477
[TBL] [Abstract][Full Text] [Related]
3. Impact of Human Epidermal Growth Factor on Tissue-Engineered Skeletal Muscle Structure and Function.
Wroblewski OM; Vega-Soto EE; Nguyen MH; Cederna PS; Larkin LM
Tissue Eng Part A; 2021 Sep; 27(17-18):1151-1159. PubMed ID: 33203338
[TBL] [Abstract][Full Text] [Related]
4. Impact of Cell Seeding Density and Cell Confluence on Human Tissue Engineered Skeletal Muscle.
Wroblewski OM; Nguyen MH; Cederna PS; Larkin LM
Tissue Eng Part A; 2022 May; 28(9-10):420-432. PubMed ID: 34652973
[TBL] [Abstract][Full Text] [Related]
5. Effects of Dexamethasone Dose and Timing on Tissue-Engineered Skeletal Muscle Units.
Larson AA; Syverud BC; Florida SE; Rodriguez BL; Pantelic MN; Larkin LM
Cells Tissues Organs; 2018; 205(4):197-207. PubMed ID: 30121672
[TBL] [Abstract][Full Text] [Related]
6. Label-Free, High-Throughput Purification of Satellite Cells Using Microfluidic Inertial Separation.
Syverud BC; Lin E; Nagrath S; Larkin LM
Tissue Eng Part C Methods; 2018 Jan; 24(1):32-41. PubMed ID: 28946802
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia promotes proliferation of human myogenic satellite cells: a potential benefactor in tissue engineering of skeletal muscle.
Koning M; Werker PM; van Luyn MJ; Harmsen MC
Tissue Eng Part A; 2011 Jul; 17(13-14):1747-58. PubMed ID: 21438665
[TBL] [Abstract][Full Text] [Related]
8. Impact of static magnetic fields on human myoblast cell cultures.
Stern-Straeter J; Bonaterra GA; Kassner SS; Faber A; Sauter A; Schulz JD; Hörmann K; Kinscherf R; Goessler UR
Int J Mol Med; 2011 Dec; 28(6):907-17. PubMed ID: 21837362
[TBL] [Abstract][Full Text] [Related]
9. Repairing Volumetric Muscle Loss in the Ovine Peroneus Tertius Following a 3-Month Recovery.
Novakova SS; Rodriguez BL; Vega-Soto EE; Nutter GP; Armstrong RE; Macpherson PCD; Larkin LM
Tissue Eng Part A; 2020 Aug; 26(15-16):837-851. PubMed ID: 32013753
[TBL] [Abstract][Full Text] [Related]
10. Impact of Human Recombinant Irisin on Tissue-Engineered Skeletal Muscle Structure and Function.
Nguyen MH; Kennedy CS; Wroblewski OM; Su E; Hwang DH; Larkin LM
Tissue Eng Part A; 2024 Jan; 30(1-2):94-101. PubMed ID: 37842832
[TBL] [Abstract][Full Text] [Related]
11. Exosomes from differentiating human skeletal muscle cells trigger myogenesis of stem cells and provide biochemical cues for skeletal muscle regeneration.
Choi JS; Yoon HI; Lee KS; Choi YC; Yang SH; Kim IS; Cho YW
J Control Release; 2016 Jan; 222():107-15. PubMed ID: 26699421
[TBL] [Abstract][Full Text] [Related]
12. A Comparison of Ovine Facial and Limb Muscle as a Primary Cell Source for Engineered Skeletal Muscle.
Rodriguez BL; Nguyen MH; Armstrong RE; Vega-Soto EE; Polkowski PM; Larkin LM
Tissue Eng Part A; 2020 Feb; 26(3-4):167-177. PubMed ID: 31469044
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-1 and microRNA-206 improve differentiation potential of human satellite cells: a novel approach for tissue engineering of skeletal muscle.
Koning M; Werker PM; van der Schaft DW; Bank RA; Harmsen MC
Tissue Eng Part A; 2012 May; 18(9-10):889-98. PubMed ID: 22070522
[TBL] [Abstract][Full Text] [Related]
14. Muscling in on stem cells.
Sinanan AC; Buxton PG; Lewis MP
Biol Cell; 2006 Apr; 98(4):203-14. PubMed ID: 16545076
[TBL] [Abstract][Full Text] [Related]
15. Focused in vivo genetic analysis of implanted engineered myofascial constructs.
Propst JT; Fann SA; Franchini JL; Lessner SM; Rose JR; Hansen KJ; Terracio L; Yost MJ
J Invest Surg; 2009; 22(1):35-45. PubMed ID: 19191156
[TBL] [Abstract][Full Text] [Related]
16. Biomimetic engineered muscle with capacity for vascular integration and functional maturation in vivo.
Juhas M; Engelmayr GC; Fontanella AN; Palmer GM; Bursac N
Proc Natl Acad Sci U S A; 2014 Apr; 111(15):5508-13. PubMed ID: 24706792
[TBL] [Abstract][Full Text] [Related]
17. The Potential of Combination Therapeutics for More Complete Repair of Volumetric Muscle Loss Injuries: The Role of Exogenous Growth Factors and/or Progenitor Cells in Implantable Skeletal Muscle Tissue Engineering Technologies.
Passipieri JA; Christ GJ
Cells Tissues Organs; 2016; 202(3-4):202-213. PubMed ID: 27825153
[TBL] [Abstract][Full Text] [Related]
18. Impact of Passaging Primary Skeletal Muscle Cell Isolates on the Engineering of Skeletal Muscle.
Wroblewski OM; Kennedy CS; Vega-Soto EE; Forester CE; Su EY; Nguyen MH; Cederna P; Larkin LM
Tissue Eng Part A; 2024 Jun; ():. PubMed ID: 38874526
[TBL] [Abstract][Full Text] [Related]
19. Function of death-associated protein 1 in proliferation, differentiation, and apoptosis of chicken satellite cells.
Shin J; McFarland DC; Strasburg GM; Velleman SG
Muscle Nerve; 2013 Nov; 48(5):777-90. PubMed ID: 23483580
[TBL] [Abstract][Full Text] [Related]
20. Characterization of human myoblast cultures for tissue engineering.
Stern-Straeter J; Bran G; Riedel F; Sauter A; Hörmann K; Goessler UR
Int J Mol Med; 2008 Jan; 21(1):49-56. PubMed ID: 18097615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
